Magnetar Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.15M | Buy |
1,790
+804
| +82% | +$821K | 0.02% | 320 |
|
|
2026
Q1 | $874K | Buy |
+986
| New | +$1,000K | 0.01% | 507 |
|
|
2025
Q1 | – | Sell |
-4,572
| Closed | -$3.53M | – | 853 |
|
|
2024
Q4 | $3.53M | Buy |
+4,572
| New | +$3.79M | 0.08% | 172 |
|
|
2024
Q2 | – | Sell |
-12,052
| Closed | -$9.38M | – | 579 |
|
|
2024
Q1 | $9.38M | Sell |
12,052
-31,080
| -72% | -$22.1M | 0.21% | 92 |
|
|
2023
Q4 | $25.1M | Sell |
43,132
-19,990
| -32% | -$11.7M | 0.64% | 53 |
|
|
2023
Q3 | $33.9M | Sell |
63,122
-28,707
| -31% | -$14.8M | 0.87% | 33 |
|
|
2023
Q2 | $43.1M | Sell |
91,829
-177,893
| -66% | -$74.6M | 0.94% | 42 |
|
|
2023
Q1 | $92.6M | Buy |
269,722
+145,875
| +118% | +$49.2M | 1.81% | 8 |
|
|
2022
Q4 | $45.3M | Buy |
123,847
+53,761
| +77% | +$19.1M | 0.77% | 30 |
|
|
2022
Q3 | $22.7M | Buy |
+70,086
| New | +$22.2M | 0.31% | 66 |
|
|
2022
Q1 | – | Sell |
-14,610
| Closed | -$4.04M | – | 1448 |
|
|
2021
Q4 | $4.04M | Sell |
14,610
-41,059
| -74% | -$10.4M | 0.04% | 452 |
|
|
2021
Q3 | $12.9M | Buy |
55,669
+16,751
| +43% | +$4.13M | 0.13% | 166 |
|
|
2021
Q2 | $8.93K | Buy |
38,918
+33,767
| +656% | +$6.78M | 0.08% | 231 |
|
|
2021
Q1 | $962K | Buy |
+5,151
| New | +$1.01M | 0.01% | 701 |
|
|
2019
Q3 | – | Sell |
-13,797
| Closed | -$1.53M | – | 541 |
|
|
2019
Q2 | $1.53M | Buy |
+13,797
| New | +$1.62M | 0.03% | 139 |
|
|
2019
Q1 | – | Sell |
-4,000
| Closed | -$463K | – | 446 |
|
|
2018
Q4 | $463K | Sell |
4,000
-90,439
| -96% | -$10.1M | 0.01% | 155 |
|
|
2018
Q3 | $10.1M | Buy |
+94,439
| New | +$9.44M | 0.18% | 58 |
|
|
2018
Q1 | – | Sell |
-24,684
| Closed | -$2.08M | – | 699 |
|
|
2017
Q4 | $2.08M | Buy |
+24,684
| New | +$2.1M | 0.04% | 112 |
|
|
2017
Q3 | – | Sell |
-42,617
| Closed | -$3.51M | – | 819 |
|
|
2017
Q2 | $3.51M | Buy |
+42,617
| New | +$3.48M | 0.05% | 149 |
|
|
2016
Q2 | – | Sell |
-12,432
| Closed | -$895K | – | 431 |
|
|
2016
Q1 | $895K | Buy |
12,432
+6,784
| +120% | +$513K | 0.01% | 138 |
|
|
2015
Q4 | $476K | Buy |
+5,648
| New | +$469K | 0.01% | 149 |
|
|
2015
Q2 | – | Sell |
-30,568
| Closed | -$2.22M | – | 445 |
|
|
2015
Q1 | $2.22M | Buy |
+30,568
| New | +$2.18M | 0.04% | 152 |
|
|
2014
Q4 | – | Sell |
-22,656
| Closed | -$1.47M | – | 206 |
|
|
2014
Q3 | $1.47M | Buy |
+22,656
| New | +$1.43M | 0.02% | 132 |
|
|
2013
Q4 | – | Sell |
-9,849
| Closed | -$496K | – | 321 |
|
|
2013
Q3 | $496K | Buy |
9,849
+1,363
| +16% | +$71.4K | 0.01% | 397 |
|
|
2013
Q2 | $417K | Buy |
+8,486
| New | +$462K | 0.01% | 317 |
|
Other funds holding LLY
Magnetar Financial's LLY Position: Q2 2026 in Review
Magnetar Financial increased its Eli Lilly (LLY) stake by 82% in Q2 2026, buying an estimated $821K and bringing the position to 1,790 shares worth $2.15M. The position accounts for 0.02% of the portfolio, ranked #320.
Magnetar Financial first reported a position in LLY in Q2 2013 and has held it in 25 quarters since. The position peaked at $92.6M in Q1 2023. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Magnetar Financial held 1,790 shares of Eli Lilly worth $2.15M as of Q2 2026.
- Magnetar Financial bought 804 Eli Lilly shares in Q2 2026, an estimated $821K.
- Eli Lilly made up 0.02% of Magnetar Financial's portfolio in Q2 2026, its #320 holding.
- Magnetar Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 25 quarters since.
- Magnetar Financial's Eli Lilly position peaked at $92.6M in Q1 2023.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.